Asia Pacific Multiplex Assays Market– Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Published Report
  • Nov 2018
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 25
  • No of Figures: 131

Asia Pacific Multiplex Assays Market, By Products & Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays, Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time PCR, Flow Cytometry, Fluorescence Detection, Luminescence, Others), Application (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (Asia-Pacific)- Industry Trends and Forecast to 2026

A Multiplex Assay is a type of immunoassay that uses magnetic beads or non-magnetic beads to determine multiple analyte in a single sample. A multiplex assay is as similar as that of an ELISA but here in multiplex assays, beads are present that are useful in binding the capture antibody. Multiplex assays are common because of their benefits nowadays in research than in clinical settings.

Protein immunoassays give data regarding quantities and forms of endogenous proteins in a given sample. Uniplex enzyme immunoassays such as enzyme-linked immunosorbent assay (ELISA) used for protein measurement from past years but they are time consuming and found to be more costly. When comparing ELISA with multiplex assays, multiplex assays offer more accurate quantitative information in a single analysis for number of analysis.

Asia Pacific multiplex assays market is expected to reach a healthy CAGR of 8.3% in the forecast period of 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Segmentation: Asia Pacific Multiplex Assays Market 

Asia Pacific multiplex assay market is categorized into five notable segments which are products & services, type, technology, application and end user.

  • On the basis of product & services the market is segmented into reagents & consumables, instruments & accessories and software and services. In 2019, reagents & consumables segment is expected to dominate the Asia Pacific multiplex assays market with 65.0% market share and is expected to reach at the highest CAGR of 8.7% in the forecast period of 2019 to 2026.

    • In September 2014, F. Hoffmann-La Roche Ltd launched new fully automated molecular diagnostic systems named as cobas 6800/8800 Systems. These systems offer results in a very short time along with highest testing capacity. With this launch the company has increased their product portfolio in market in diagnostics field.

  • On the basis of type, the market is segmented into protein multiplex assays, nucleic acid multiplex assays and cell-based multiplex assays. Protein multiplex assays are sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays are sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays. In 2019, a nucleic acid multiplex assay segment is expected to dominate the Asia Pacific multiplex assays market with 49.6% market share and is expected to grow at the highest CAGR of 8.8% in the forecast period of 2019 to 2026.

    • In June 2015, Abcam plc, launched a range of multiplex miRNA profiling assays. The launched assay has the ability to give high-throughput validation of miRNA biomarkers on the basis of Abcam’s new Firefly particle technology. Launching this product was the opportunities to Abcam for its Firefly particle technology that bring the Asia Pacific researchers for miRNA research.

  • On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, polymerase chain reaction (PCR), protein microarray and others. In 2019, protein microarray segment is expected to dominate the Asia Pacific multiplex assays market with 58.3% market share and is expected to grow at the CAGR of 8.5% in the forecast period of 2019 to 2026. However, polymerase chain reaction (PCR) segment is expected to grow at the highest CAGR of 9.2% in the forecast period of 2019 to 2026.

    • In July 2018, BD (Becton, Dickinson and Company) launched BD AbSeq assay for simultaneous RNA and protein expression analysis assay. The systems include the BD Rhapsody Express system and the BD single-cell multiplexing kit. Launch of this product helped in increasing one more product in company’s product portfolio.

  • On the basis of application the market is segmented into research & development and clinical diagnostics. Research & development is sub-segmented into drug discovery & development and biomarker discovery & validation. Clinical diagnostics is sub-segmented into infectious diseases, cancer, cardiovascular diseases, infectious diseases, autoimmune diseases, allergies, nervous system disorders, metabolism & endocrinology disorders and others.

    • In 2019, clinical diagnostics segment is expected to dominate the Asia Pacific multiplex assays market with 56.0% market share and is expected to grow at the highest CAGR of 8.8% in the forecast period of 2019 to 2026.
    • In June 2015, MESO SCALE DIAGNOSTICS, LLC. at the 2015 AAPS National Biotechnology Conference, launched its new Biomarker Services. This service offered biomarker screening and assay development services to their customer for discovery and exploratory studies to validated products.

  • On the basis of end user the market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others. In 2019, a hospital segment is expected to dominate the Asia Pacific multiplex assays market with 38.1% market share and is expected to grow at the highest CAGR of 9.1% in the forecast period of 2019 to 2026.

    • In January 2016, Thermo Fisher Scientific acquired Affymetrix (U.S.). The acquisition of Affymetrix with Thermo Fisher Scientific helped Thermo Fisher Scientific Company in strengthening the biosciences field and creating new market opportunities for in genetic analysis.

Competitive Analysis: Asia Pacific Multiplex Assays Market 

Some of the prominent participants operating in this market are BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Cepheid, Siemens AG, Hologic Inc., Luminex Corporation. , MESO SCALE DIAGNOSTICS, LLC., QIAGEN, PerkinElmer Inc. , Illumina, Inc. , AGENA BIOSCIENCE, INC. , Olink , Randox Laboratories Ltd., Bio-Techne. , Agilent Technologies, Agilent Technologies, Sysmex Corporation and among others.

Product launch:

  • In May 2018, Bio-Rad Laboratories, Inc. launched the Bio-Plex Pro Human Cytokine Screening Panel. This product is the first validated high-performance multiplex assay on the market. The panel has the ability to identify and quantify 48 different analytes. This is applicable for identification and estimation of analytes for heart disease, autoimmunity and allergy, cancer, and many other conditions. Launching this product helped the company in increasing their product portfolio.
  • In May 2017, Bio-Rad Laboratories, Inc. launched the Bio-Plex Pro Human Apolipoprotein Panel. This product has 10-plex panel that allows researchers to detect and quantify quickly key human apolipoproteins associated with cardiovascular disease, especially within the statin pathway. The panel offers the largest number of apolipoproteins on the market. It is one of the easiest way for detection for the problems related to cardiovascular and others and with this company has added one more product in their product portfolio for serving it to their customer in market.
  • In June 2018, QIAGEN launched the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit. This kit was launched with a new generation of reagents to allow the most accurate microbial community profiling from complex microbiome samples. This product provides comprehensive and robust profiling of bacterial and fungal communities. With this launch one more product got added to company’s product portfolio.

Research Methodology: Asia Pacific Multiplex Assays Market 

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers


SKU-

LIST OF TABLES ASIA-PACIFIC MULTIPLEX ASSAYS MARKET

TABLE 1 COST OF FEW MULTIPLEX INSTRUMENTS TABLE 2 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 3 ASIA-PACIFIC REAGENTS & CONSUMABLES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 4 ASIA-PACIFIC INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 5 ASIA-PACIFIC INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 6 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 7 ASIA-PACIFIC NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 8 ASIA-PACIFIC NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 9 ASIA-PACIFIC PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 10 ASIA-PACIFIC PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 11 ASIA-PACIFIC CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 12 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 13 ASIA-PACIFIC PROTEIN MICROARRAY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 ASIA-PACIFIC POLYMERASE CHAIN REACTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 15 ASIA-PACIFIC MULTIPLEX REAL-TIME PCR IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 ASIA-PACIFIC FLOW CYTOMETRY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 17 ASIA-PACIFIC FLUORESCENCE DETECTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 18 ASIA-PACIFIC LUMINESCENCE IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 19 ASIA-PACIFIC OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 20 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 21 ASIA-PACIFIC CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 ASIA-PACIFIC CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 23 ASIA-PACIFIC RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 ASIA-PACIFIC RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 25 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 26 ASIA-PACIFIC HOSPITALS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 27 ASIA-PACIFIC CLINICAL LABORATORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 28 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 29 ASIA-PACIFIC RESEARCH INSTITUTES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 30 ASIA-PACIFIC OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 31 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 32 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 33 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 34 ASIA-PACIFIC NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 35 ASIA-PACIFIC PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 36 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 37 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 38 ASIA-PACIFIC CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 39 ASIA-PACIFIC RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 40 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 41 CHINA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 42 CHINA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 43 CHINA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 44 CHINA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 45 CHINA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 46 CHINA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 47 CHINA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 48 CHINA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 49 CHINA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 50 JAPAN MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 51 JAPAN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 52 JAPAN NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 53 JAPAN PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 54 JAPAN MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 55 JAPAN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 56 JAPAN CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 57 JAPAN RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 58 JAPAN MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 59 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 60 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 61 SOUTH KOREA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 62 SOUTH KOREA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 63 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 64 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 65 SOUTH KOREA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 66 SOUTH KOREA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 67 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 68 INDIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 69 INDIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 70 INDIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 71 INDIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 72 INDIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 73 INDIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 74 INDIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 75 INDIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 76 INDIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 77 SINGAPORE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 78 SINGAPORE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 79 SINGAPORE NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 80 SINGAPORE PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 81 SINGAPORE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 82 SINGAPORE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 83 SINGAPORE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 84 SINGAPORE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 85 SINGAPORE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 86 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 87 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 88 AUSTRALIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 89 AUSTRALIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 90 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 91 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 92 AUSTRALIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 93 AUSTRALIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 94 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 95 THAILAND MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 96 THAILAND MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 97 THAILAND NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 98 THAILAND PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 99 THAILAND MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 100 THAILAND MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 101 THAILAND CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 102 THAILAND RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 103 THAILAND MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 104 MALAYSIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 105 MALAYSIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 106 MALAYSIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 107 MALAYSIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 108 MALAYSIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 109 MALAYSIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 110 MALAYSIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 111 MALAYSIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 112 MALAYSIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 113 INDONESIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 114 INDONESIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 115 INDONESIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 116 INDONESIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 117 INDONESIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 118 INDONESIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 119 INDONESIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 120 INDONESIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 121 INDONESIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 122 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 123 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 124 PHILIPPINES NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 125 PHILIPPINES PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 126 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 127 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 128 PHILIPPINES CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 129 PHILIPPINES RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 130 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 131 REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19